Preinfection laboratory parameters may predict COVID‐19 severity in tumor patients

BACKGROUND: Infection with SARS‐CoV‐2 leads to COVID‐19, the course of which is highly variable and depends on numerous patient‐specific risk factors. Patients with tumor diseases are considered to be more susceptible to severe COVID‐19; however, they also represent a heterogeneous group of individu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiani, Alexander, Roesch, Romina, Wendtner, Clemens M., Kullmann, Frank, Kubin, Thomas, Südhoff, Thomas, Augustin, Marinela, Schaich, Markus, Müller‐Naendrup, Clemens, Illerhaus, Gerald, Hartmann, Frank, Hebart, Holger, Seggewiss‐Bernhardt, Ruth, Bentz, Martin, Späth‐Schwalbe, Ernst, Reimer, Peter, Kaiser, Ulrich, Kapp, Markus, Graeven, Ullrich, Chemnitz, Jens‐Marcus, Baesecke, Jörg, Lambertz, Helmut, Naumann, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267142/
https://www.ncbi.nlm.nih.gov/pubmed/34121360
http://dx.doi.org/10.1002/cam4.4023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267142/
https://www.ncbi.nlm.nih.gov/pubmed/34121360
http://dx.doi.org/10.1002/cam4.4023

Ejemplares similares